§ 58-37-4.2. Listed controlled substances. (Effective 3/20/2014)

     The following substances, their analogs, homologs, and synthetic equivalents are listed controlled substances:

(1) AB-001;

(2) AB-PINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;

(3) AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl) methyl]-1H-indazole-3-carboxamide;

(4) AKB48;

(5) alpha-Pyrrolidinovalerophenone (alpha-PVP);

(6) AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;

(7) AM-1248;

(8) AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;

(9) AM-2233;

(10) AM-679;

(11) A796,260;

(12) Butylone;

(13) CP 47,497 and its C6, C8, and C9 homologs; 2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol;

(14) Diisopropyltryptamine (DiPT);

(15) Ethylone;

(16) Ethylphenidate;

(17) Fluoroisocathinone;

(18) Fluoromethamphetamine;

(19) Fluoromethcathinone;

(20) HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

(21) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

(22) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;

(23) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as 1-Pentyl-3-(1-naphthoyl)indole};

(24) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;

(25) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as 1-Butyl-3-(1-naphthoyl)indole};

(26) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;

(27) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);

(28) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;

(29) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;

(30) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;

(31) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;

(32) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;

(33) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;

(34) MAM-2201;

(35) MAM-2201; (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;

(36) Methoxetamine;

(37) Naphyrone;

(38) PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;

(39) Pentedrone;

(40) Pentylone;

(41) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;

(42) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also known as BTW-8 and SR-18};

(43) STS-135;

(44) UR-144;

(45) UR-144 N-(5-chloropentyl) analog;

(46) XLR11;

(47) 2C-C;

(48) 2C-D;

(49) 2C-E;

(50) 2C-H;

(51) 2C-I;

(52) 2C-N;

(53) 2C-P;

(54) 2C-T-2;

(55) 2C-T-4;

(56) 2NE1;

(57) 25I-NBOMe;

(58) 2,5-Dimethoxy-4-chloroamphetamine (DOC);

(59) 4-methylmethcathinone {also known as mephedrone};

(60) 3,4-methylenedioxypyrovalerone {also known as MDPV};

(61) 3,4-Methylenedioxymethcathinone {also known as methylone};

(62) 4-methoxymethcathinone;

(63) 4-Methyl-alpha-pyrrolidinopropiophenone;

(64) 4-Methylethcathinone;

(65) 5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;

(66) 5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester;

(67) 5-Iodo-2-aminoindane (5-IAI);

(68) 5-MeO-DALT;

(69) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;

(70) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; and

(71) 25H-NBOMe; 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.

Amended by Chapter 23, 2014 General Session